206 related articles for article (PubMed ID: 26842068)
1. Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.
Al-Shawi R; Tennent GA; Millar DJ; Richard-Londt A; Brandner S; Werring DJ; Simons JP; Pepys MB
Open Biol; 2016 Feb; 6(2):150202. PubMed ID: 26842068
[TBL] [Abstract][Full Text] [Related]
2. Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.
Kolstoe SE; Ridha BH; Bellotti V; Wang N; Robinson CV; Crutch SJ; Keir G; Kukkastenvehmas R; Gallimore JR; Hutchinson WL; Hawkins PN; Wood SP; Rossor MN; Pepys MB
Proc Natl Acad Sci U S A; 2009 May; 106(18):7619-23. PubMed ID: 19372378
[TBL] [Abstract][Full Text] [Related]
3. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
5. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
6. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
7. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
8. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
[TBL] [Abstract][Full Text] [Related]
9. Intracisternal injection of beta-amyloid seeds promotes cerebral amyloid angiopathy.
Yuan Q; Xian YF; Huang YF; Wu W; Song YQ; Lin ZX
Brain Behav Immun; 2020 Oct; 89():628-640. PubMed ID: 32739364
[TBL] [Abstract][Full Text] [Related]
10. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
11. Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes.
Trumbore CN
J Alzheimers Dis; 2016 Sep; 54(2):457-70. PubMed ID: 27567812
[TBL] [Abstract][Full Text] [Related]
12. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
13. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
[TBL] [Abstract][Full Text] [Related]
14. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
Jia J; Cui M; Dai J; Liu B
Mol Pharm; 2015 Aug; 12(8):2937-46. PubMed ID: 26065726
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
17. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
Pepys MB
Front Immunol; 2018; 9():2382. PubMed ID: 30459761
[TBL] [Abstract][Full Text] [Related]
18. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
Bodin K; Ellmerich S; Kahan MC; Tennent GA; Loesch A; Gilbertson JA; Hutchinson WL; Mangione PP; Gallimore JR; Millar DJ; Minogue S; Dhillon AP; Taylor GW; Bradwell AR; Petrie A; Gillmore JD; Bellotti V; Botto M; Hawkins PN; Pepys MB
Nature; 2010 Nov; 468(7320):93-7. PubMed ID: 20962779
[TBL] [Abstract][Full Text] [Related]
20. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
Shi J; Perry G; Berridge MS; Aliev G; Siedlak SL; Smith MA; LaManna JC; Friedland RP
J Nucl Med; 2002 Aug; 43(8):1044-51. PubMed ID: 12163630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
